N
Nordic Bioscience
World-leading specialist in biomarkers, clinical development and speciality laboratory services
About Nordic Bioscience
Nordic Bioscience is a specialized company focused on biomarker development and clinical trials, particularly in the fields of rheumatology and fibrosis. Operating in the biotechnology and pharmaceutical sectors, the company leverages over 25 years of experience to offer customized assay development and research programs. Nordic Bioscience serves pharmaceutical companies, research institutions, and healthcare providers by providing high-quality biomarker analysis and clinical trial services. The company generates revenue through service contracts, research collaborations, and licensing agreements. Its business model is built on delivering precision medicine solutions using unique biomarker technologies, which help in the early detection and treatment of diseases. The company is privately owned, allowing for swift decision-making and adaptability to market needs.
Source: Dealroom company dataAt a glance
- Founded
- 1991
- Headquarters
- Herlev, Denmark
- Sector
- Biotech & Life Sciences
- Power Law
- Colt$25–100M revenue
Knowledge graph
More headlines
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series B and later1 investor entered at this stage
Source: Dealroom Talent Intelligence.
Global footprint
team presence
across markets
Market sentiment
An AI-synthesised read of the highest-engagement posts about Nordic Bioscience on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Nordic Bioscience on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.